Non-pharmacological therapies for postviral syndromes, including Long COVID: a systematic review and meta-analysis protocol

IntroductionPostviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the SARS-CoV-2 virus and subsequent development of COVID-19 has shown to have similar effects with individuals continuing to exhibit symptoms fo...

Full description

Saved in:
Bibliographic Details
Published inBMJ open Vol. 12; no. 4; p. e057885
Main Authors Chandan, Joht Singh, Brown, Kirsty, Simms-Williams, Nikita, Camaradou, Jenny, Bashir, Nasir, Heining, Dominic, Aiyegbusi, Olalekan Lee, Turner, Grace, Cruz Rivera, Samantha, Hotham, Richard, Nirantharakumar, Krishnarajah, Sivan, Manoj, Khunti, Kamlesh, Raindi, Devan, Marwaha, Steven, Hughes, Sarah E, McMullan, Christel, Calvert, Melanie, Haroon, Shamil
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 11.04.2022
BMJ Publishing Group LTD
BMJ Publishing Group
SeriesProtocol
Subjects
Online AccessGet full text

Cover

Loading…
Abstract IntroductionPostviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the SARS-CoV-2 virus and subsequent development of COVID-19 has shown to have similar effects with individuals continuing to exhibit symptoms for greater than 12 weeks. The sustained presence of symptoms is variably referred to as ‘post COVID-19 syndrome’, ‘post-COVID condition’ or more commonly ‘Long COVID’. Knowledge of the long-term health impacts and treatments for Long COVID are evolving. To minimise overlap with existing work in the field exploring treatments of Long COVID, we have only chosen to focus on non-pharmacological treatments.AimsThis review aims to summarise the effectiveness of non-pharmacological treatments for PVS, including Long COVID. A secondary aim is to summarise the symptoms and health impacts associated with PVS in individuals recruited to treatment studies.Methods and analysisPrimary electronic searches will be performed in bibliographic databases including: Embase, MEDLINE, PyscINFO, CINAHL and MedRxiv from 1 January 2001 to 29 October 2021. At least two independent reviewers will screen each study for inclusion and data will be extracted from all eligible studies onto a data extraction form. The quality of all included studies will be assessed using Cochrane risk of bias tools and the Newcastle-Ottawa grading system. Non-pharmacological treatments for PVS and Long COVID will be narratively summarised and effect estimates will be pooled using random effects meta-analysis where there is sufficient methodological homogeneity. The symptoms and health impacts reported in the included studies on non-pharmacological interventions will be extracted and narratively reported.Ethics and disseminationThis systematic review does not require ethical approval. The findings from this study will be submitted for peer-reviewed publication, shared at conference presentations and disseminated to both clinical and patient groups.PROSPERO registration numberThe review will adhere to this protocol which has also been registered with PROSPERO (CRD42021282074).
AbstractList IntroductionPostviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the SARS-CoV-2 virus and subsequent development of COVID-19 has shown to have similar effects with individuals continuing to exhibit symptoms for greater than 12 weeks. The sustained presence of symptoms is variably referred to as ‘post COVID-19 syndrome’, ‘post-COVID condition’ or more commonly ‘Long COVID’. Knowledge of the long-term health impacts and treatments for Long COVID are evolving. To minimise overlap with existing work in the field exploring treatments of Long COVID, we have only chosen to focus on non-pharmacological treatments.AimsThis review aims to summarise the effectiveness of non-pharmacological treatments for PVS, including Long COVID. A secondary aim is to summarise the symptoms and health impacts associated with PVS in individuals recruited to treatment studies.Methods and analysisPrimary electronic searches will be performed in bibliographic databases including: Embase, MEDLINE, PyscINFO, CINAHL and MedRxiv from 1 January 2001 to 29 October 2021. At least two independent reviewers will screen each study for inclusion and data will be extracted from all eligible studies onto a data extraction form. The quality of all included studies will be assessed using Cochrane risk of bias tools and the Newcastle-Ottawa grading system. Non-pharmacological treatments for PVS and Long COVID will be narratively summarised and effect estimates will be pooled using random effects meta-analysis where there is sufficient methodological homogeneity. The symptoms and health impacts reported in the included studies on non-pharmacological interventions will be extracted and narratively reported.Ethics and disseminationThis systematic review does not require ethical approval. The findings from this study will be submitted for peer-reviewed publication, shared at conference presentations and disseminated to both clinical and patient groups.PROSPERO registration numberThe review will adhere to this protocol which has also been registered with PROSPERO (CRD42021282074).
Introduction Postviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the SARS-CoV-2 virus and subsequent development of COVID-19 has shown to have similar effects with individuals continuing to exhibit symptoms for greater than 12 weeks. The sustained presence of symptoms is variably referred to as ‘post COVID-19 syndrome’, ‘post-COVID condition’ or more commonly ‘Long COVID’. Knowledge of the long-term health impacts and treatments for Long COVID are evolving. To minimise overlap with existing work in the field exploring treatments of Long COVID, we have only chosen to focus on non-pharmacological treatments.Aims This review aims to summarise the effectiveness of non-pharmacological treatments for PVS, including Long COVID. A secondary aim is to summarise the symptoms and health impacts associated with PVS in individuals recruited to treatment studies.Methods and analysis Primary electronic searches will be performed in bibliographic databases including: Embase, MEDLINE, PyscINFO, CINAHL and MedRxiv from 1 January 2001 to 29 October 2021. At least two independent reviewers will screen each study for inclusion and data will be extracted from all eligible studies onto a data extraction form. The quality of all included studies will be assessed using Cochrane risk of bias tools and the Newcastle-Ottawa grading system. Non-pharmacological treatments for PVS and Long COVID will be narratively summarised and effect estimates will be pooled using random effects meta-analysis where there is sufficient methodological homogeneity. The symptoms and health impacts reported in the included studies on non-pharmacological interventions will be extracted and narratively reported.Ethics and dissemination This systematic review does not require ethical approval. The findings from this study will be submitted for peer-reviewed publication, shared at conference presentations and disseminated to both clinical and patient groups.PROSPERO registration number The review will adhere to this protocol which has also been registered with PROSPERO (CRD42021282074).
Postviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the SARS-CoV-2 virus and subsequent development of COVID-19 has shown to have similar effects with individuals continuing to exhibit symptoms for greater than 12 weeks. The sustained presence of symptoms is variably referred to as 'post COVID-19 syndrome', 'post-COVID condition' or more commonly 'Long COVID'. Knowledge of the long-term health impacts and treatments for Long COVID are evolving. To minimise overlap with existing work in the field exploring treatments of Long COVID, we have only chosen to focus on non-pharmacological treatments. This review aims to summarise the effectiveness of non-pharmacological treatments for PVS, including Long COVID. A secondary aim is to summarise the symptoms and health impacts associated with PVS in individuals recruited to treatment studies. Primary electronic searches will be performed in bibliographic databases including: Embase, MEDLINE, PyscINFO, CINAHL and MedRxiv from 1 January 2001 to 29 October 2021. At least two independent reviewers will screen each study for inclusion and data will be extracted from all eligible studies onto a data extraction form. The quality of all included studies will be assessed using Cochrane risk of bias tools and the Newcastle-Ottawa grading system. Non-pharmacological treatments for PVS and Long COVID will be narratively summarised and effect estimates will be pooled using random effects meta-analysis where there is sufficient methodological homogeneity. The symptoms and health impacts reported in the included studies on non-pharmacological interventions will be extracted and narratively reported. This systematic review does not require ethical approval. The findings from this study will be submitted for peer-reviewed publication, shared at conference presentations and disseminated to both clinical and patient groups. The review will adhere to this protocol which has also been registered with PROSPERO (CRD42021282074).
Author Raindi, Devan
Marwaha, Steven
Cruz Rivera, Samantha
Haroon, Shamil
Brown, Kirsty
Nirantharakumar, Krishnarajah
Khunti, Kamlesh
Simms-Williams, Nikita
McMullan, Christel
Aiyegbusi, Olalekan Lee
Hotham, Richard
Sivan, Manoj
Hughes, Sarah E
Calvert, Melanie
Heining, Dominic
Camaradou, Jenny
Chandan, Joht Singh
Bashir, Nasir
Turner, Grace
AuthorAffiliation 12 Institute for Mental Health , University of Birmingham , Birmingham , UK
5 University Hospitals Birmingham NHS Foundation Trust , Birmingham , UK
3 COVID END Evidence Network , UK , UK
7 NIHR Birmingham Biomedical Research Centre , University Hospitals Birmingham NHS Foundation Trust , Birmingham , UK
11 Department of Health Sciences , University of Leicester , Leicester , UK
8 Birmingham Health Partners Centre for Regulatory Science and Innovation , University of Birmingham , Birmingham , UK
10 University of Leeds , Leeds , UK
6 Centre for Patient-Reported Outcomes Research , University of Birmingham , Birmingham , UK
2 Health Data Research UK , Birmingham , UK
13 Centre for Patient Reported Outcomes Research and Institute of Applied Health Research , University of Birmingham , Birmingham , UK
9 National Institute for Health Research (NIHR) Applied Research Centre West Midlands , University of Birmingham , Birmingham , UK
1 Institute of Applied Health Research , University of Birmingham , Bir
AuthorAffiliation_xml – name: 7 NIHR Birmingham Biomedical Research Centre , University Hospitals Birmingham NHS Foundation Trust , Birmingham , UK
– name: 1 Institute of Applied Health Research , University of Birmingham , Birmingham , UK
– name: 6 Centre for Patient-Reported Outcomes Research , University of Birmingham , Birmingham , UK
– name: 8 Birmingham Health Partners Centre for Regulatory Science and Innovation , University of Birmingham , Birmingham , UK
– name: 10 University of Leeds , Leeds , UK
– name: 2 Health Data Research UK , Birmingham , UK
– name: 5 University Hospitals Birmingham NHS Foundation Trust , Birmingham , UK
– name: 3 COVID END Evidence Network , UK , UK
– name: 12 Institute for Mental Health , University of Birmingham , Birmingham , UK
– name: 9 National Institute for Health Research (NIHR) Applied Research Centre West Midlands , University of Birmingham , Birmingham , UK
– name: 11 Department of Health Sciences , University of Leicester , Leicester , UK
– name: 13 Centre for Patient Reported Outcomes Research and Institute of Applied Health Research , University of Birmingham , Birmingham , UK
– name: 4 School of Dentistry , University of Birmingham , Birmingham , UK
Author_xml – sequence: 1
  givenname: Joht Singh
  orcidid: 0000-0002-9561-5141
  surname: Chandan
  fullname: Chandan, Joht Singh
  email: j.s.chandan.1@bham.ac.uk
  organization: Health Data Research UK, Birmingham, UK
– sequence: 2
  givenname: Kirsty
  orcidid: 0000-0001-9403-1593
  surname: Brown
  fullname: Brown, Kirsty
  organization: Institute of Applied Health Research, University of Birmingham, Birmingham, UK
– sequence: 3
  givenname: Nikita
  orcidid: 0000-0002-4926-1995
  surname: Simms-Williams
  fullname: Simms-Williams, Nikita
  organization: Institute of Applied Health Research, University of Birmingham, Birmingham, UK
– sequence: 4
  givenname: Jenny
  surname: Camaradou
  fullname: Camaradou, Jenny
  organization: COVID END Evidence Network, UK, UK
– sequence: 5
  givenname: Nasir
  surname: Bashir
  fullname: Bashir, Nasir
  organization: School of Dentistry, University of Birmingham, Birmingham, UK
– sequence: 6
  givenname: Dominic
  surname: Heining
  fullname: Heining, Dominic
  organization: University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
– sequence: 7
  givenname: Olalekan Lee
  orcidid: 0000-0001-9122-8251
  surname: Aiyegbusi
  fullname: Aiyegbusi, Olalekan Lee
  organization: National Institute for Health Research (NIHR) Applied Research Centre West Midlands, University of Birmingham, Birmingham, UK
– sequence: 8
  givenname: Grace
  orcidid: 0000-0002-9783-9413
  surname: Turner
  fullname: Turner, Grace
  organization: Centre for Patient-Reported Outcomes Research, University of Birmingham, Birmingham, UK
– sequence: 9
  givenname: Samantha
  orcidid: 0000-0002-1566-6804
  surname: Cruz Rivera
  fullname: Cruz Rivera, Samantha
  organization: Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK
– sequence: 10
  givenname: Richard
  surname: Hotham
  fullname: Hotham, Richard
  organization: Institute of Applied Health Research, University of Birmingham, Birmingham, UK
– sequence: 11
  givenname: Krishnarajah
  surname: Nirantharakumar
  fullname: Nirantharakumar, Krishnarajah
  organization: Health Data Research UK, Birmingham, UK
– sequence: 12
  givenname: Manoj
  orcidid: 0000-0002-0334-2968
  surname: Sivan
  fullname: Sivan, Manoj
  organization: University of Leeds, Leeds, UK
– sequence: 13
  givenname: Kamlesh
  orcidid: 0000-0003-2343-7099
  surname: Khunti
  fullname: Khunti, Kamlesh
  organization: Department of Health Sciences, University of Leicester, Leicester, UK
– sequence: 14
  givenname: Devan
  surname: Raindi
  fullname: Raindi, Devan
  organization: School of Dentistry, University of Birmingham, Birmingham, UK
– sequence: 15
  givenname: Steven
  surname: Marwaha
  fullname: Marwaha, Steven
  organization: Institute for Mental Health, University of Birmingham, Birmingham, UK
– sequence: 16
  givenname: Sarah E
  orcidid: 0000-0001-5656-1198
  surname: Hughes
  fullname: Hughes, Sarah E
  organization: National Institute for Health Research (NIHR) Applied Research Centre West Midlands, University of Birmingham, Birmingham, UK
– sequence: 17
  givenname: Christel
  orcidid: 0000-0002-0878-1513
  surname: McMullan
  fullname: McMullan, Christel
  organization: Centre for Patient-Reported Outcomes Research, University of Birmingham, Birmingham, UK
– sequence: 18
  givenname: Melanie
  orcidid: 0000-0002-1856-837X
  surname: Calvert
  fullname: Calvert, Melanie
  organization: Centre for Patient Reported Outcomes Research and Institute of Applied Health Research, University of Birmingham, Birmingham, UK
– sequence: 19
  givenname: Shamil
  orcidid: 0000-0002-0096-1413
  surname: Haroon
  fullname: Haroon, Shamil
  organization: Institute of Applied Health Research, University of Birmingham, Birmingham, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35410933$$D View this record in MEDLINE/PubMed
BookMark eNp9kk2P0zAQhiO0iF2W_QVIKBIXDoT1Z-xwQELlq1LFXoCrNXHt1lViBzspqvjzuKQsuxzwwbbGz7wzHr2PizMfvCmKpxi9wpjW122_C4PxFUEEV4gLKfmD4oIgxqoacX52535eXKW0Q3kx3nBOHhXnlDOMGkovip-fg6-GLcQedOjCxmnoynFrIgzOpNKGWA4hjXsXczwd_DqG3qSXpfO6m9bOb8pVyNvi5tvy3esSMpJG08PodBnN3pkfJfh12ZsRKvDQHZJL5RDDGHK1J8VDC10yV6fzsvj64f2XxadqdfNxuXi7qlpOm7EyxFpBkSAWamsBA60FozUXDWNYcipqCaTFLWFUctRKYcBSjKHBxBrSSHpZLGfddYCdGqLrIR5UAKd-B0LcKIi5486oVovGSmN0yxmTINoaa6ElB011DTXJWm9mrWFqe7PWxo95MvdE7794t1WbsFcNQoTwYzMvTgIxfJ9MGlXvkjZdB96EKSlSs4ZLgZDI6PN_0F2YYp7iTBHZNOxI0ZnSMaQUjb1tBiN19Io6eUUdvaJmr-SsZ3f_cZvzxxkZuJ6BnP237v8kfwEues6k
CitedBy_id crossref_primary_10_1371_journal_pone_0281884
crossref_primary_10_3238_arztebl_m2022_0409
crossref_primary_10_2196_50230
crossref_primary_10_3389_phrs_2024_1606966
crossref_primary_10_1002_cesm_12001
crossref_primary_10_1016_j_explore_2024_04_004
crossref_primary_10_3390_ijerph20043477
crossref_primary_10_1038_s41591_023_02445_x
Cites_doi 10.3389/fmed.2021.653516
10.1046/j.1440-1843.2003.00522.x
10.1136/bmj.g7647
10.1136/bmj.39489.470347.AD
10.1016/S0140-6736(21)00947-8
10.1016/j.bbi.2011.06.016
10.1038/nrn3087
10.3389/fped.2018.00373
10.1377/hlthaff.2021.00619
10.1016/S0140-6736(20)32705-7
10.1016/j.rmed.2020.106197
10.1136/bmj.n693
10.1016/S2215-0366(20)30203-0
10.1111/irv.12566
10.1378/chest.128.4.2247
10.1016/S1473-3099(21)00043-8
10.1016/j.lanepe.2021.100122
10.1177/01410768211032850
10.1136/bmj.i4919
10.1136/bmj.l4898
10.1016/S0140-6736(20)32656-8
10.30773/pi.2018.10.22.3
10.4103/1673-5374.152369
10.1136/bmjpo-2020-000797
10.1378/chest.128.3.1393
10.1016/S0140-6736(21)00446-3
10.1136/bmj.38933.585764.AE
10.1136/bmj.n1648
10.1155/2019/9342792
10.1080/21641846.2020.1778227
10.1086/518615
10.1136/bmj.j4008
10.1186/1471-2334-6-15
10.1016/S0025-6196(11)60670-8
10.1101/2020.10.19.20214494
10.1136/bmj.j3453
10.1016/s0140-6736(21)00947-8
10.4065/84.11.1001
10.1136/bmj.n71
10.1101/2021.06.28.21259452
ContentType Journal Article
Copyright Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. 2022
Copyright_xml – notice: Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
– notice: 2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. 2022
DBID 9YT
ACMMV
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7RV
7X7
7XB
88E
88G
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
BTHHO
CCPQU
COVID
DWQXO
FYUFA
GHDGH
GNUQQ
K9-
K9.
KB0
M0R
M0S
M1P
M2M
NAPCQ
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOA
DOI 10.1136/bmjopen-2021-057885
DatabaseName BMJ Open Access Journals
BMJ Journals:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
BMJ Journals
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Consumer Health Database
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Psychology Database
Nursing & Allied Health Premium
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest One Psychology
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest Family Health
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: ACMMV
  name: BMJ Journals:Open Access
  url: https://journals.bmj.com/
  sourceTypes: Publisher
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 2044-6055
EndPage e057885
ExternalDocumentID oai_doaj_org_article_bc79f8eecb5448a7b61c7c85ac3c6a62
10_1136_bmjopen_2021_057885
35410933
bmjopen
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: National Institute for Health Research
  grantid: COV-LT-0013
  funderid: http://dx.doi.org/10.13039/501100000272
– fundername: Medical Research Council
  grantid: MC_PC_20050
– fundername: ;
  grantid: COV-LT-0013
GroupedDBID ---
3V.
4.4
53G
5VS
7RV
7X7
7~R
88E
8FI
8FJ
9YT
ABUWG
ACGFS
ACMMV
ADBBV
AENEX
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BKNYI
BPHCQ
BTFSW
BTHHO
CCPQU
DIK
DWQXO
EBS
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
HZ~
K9-
KQ8
M0R
M1P
M2M
M48
M~E
NAPCQ
O9-
OK1
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
PSYQQ
RHF
RHI
RMJ
RPM
UKHRP
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ADRAZ
BVXVI
CITATION
EJD
7XB
8FK
COVID
K9.
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-b539t-e2ff73072fa6ffa1a367436579441853768a2b1b243850b87eaf311a912fe2983
IEDL.DBID RPM
ISSN 2044-6055
IngestDate Tue Oct 22 15:06:38 EDT 2024
Tue Sep 17 21:26:44 EDT 2024
Sat Aug 17 01:57:39 EDT 2024
Wed Dec 18 16:24:26 EST 2024
Thu Nov 21 21:28:28 EST 2024
Sat Sep 28 08:17:40 EDT 2024
Tue Nov 26 16:40:10 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords COVID-19
INFECTIOUS DISEASES
REHABILITATION MEDICINE
Language English
License This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b539t-e2ff73072fa6ffa1a367436579441853768a2b1b243850b87eaf311a912fe2983
Notes Protocol
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
MC and SH are joint senior authors.
JSC and KB are joint first authors.
ORCID 0000-0003-2343-7099
0000-0002-9561-5141
0000-0001-9122-8251
0000-0002-1566-6804
0000-0002-0334-2968
0000-0001-9403-1593
0000-0002-4926-1995
0000-0002-9783-9413
0000-0001-5656-1198
0000-0002-0878-1513
0000-0002-0096-1413
0000-0002-1856-837X
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002258/
PMID 35410933
PQID 2649289947
PQPubID 2040975
ParticipantIDs doaj_primary_oai_doaj_org_article_bc79f8eecb5448a7b61c7c85ac3c6a62
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9002258
proquest_miscellaneous_2649587007
proquest_journals_2649289947
crossref_primary_10_1136_bmjopen_2021_057885
pubmed_primary_35410933
bmj_journals_10_1136_bmjopen_2021_057885
PublicationCentury 2000
PublicationDate 2022-04-11
PublicationDateYYYYMMDD 2022-04-11
PublicationDate_xml – month: 04
  year: 2022
  text: 2022-04-11
  day: 11
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
– name: BMA House, Tavistock Square, London, WC1H 9JR
PublicationSeriesTitle Protocol
PublicationTitle BMJ open
PublicationTitleAbbrev BMJ Open
PublicationTitleAlternate BMJ Open
PublicationYear 2022
Publisher British Medical Journal Publishing Group
BMJ Publishing Group LTD
BMJ Publishing Group
Publisher_xml – name: British Medical Journal Publishing Group
– name: BMJ Publishing Group LTD
– name: BMJ Publishing Group
References Sterne, Savović, Page (R46) 2019; 366
Guyatt, Oxman, Vist (R49) 2008; 336
Schultz, Hilliard, Cooper (R23) 2009; 84
Gupta, Cantor, Simon (R4) 2021; 40
Daher, Balfanz, Cornelissen (R5) 2020; 174
Wells, Shea, O’Connell (R45) 2015
Rogers, Chesney, Oliver (R25) 2020; 7
Malik, Asprusten, Pedersen (R30) 2020; 4
Salamanna, Veronesi, Martini (R13) 2021; 8
Vernon, Whistler, Cameron (R35) 2006; 6
Shamseer, Moher, Clarke (R40) 2015; 349
Hsieh, Lee, Cho (R21) 2018; 12
Chan, Zheng, Mok (R24) 2003; 8 Suppl
Hui, Wong, Ko (R19) 2005; 128
Ong, Ng, Lee (R20) 2005; 128
Sterne, Hernán, Reeves (R47) 2016; 355
Gorna, MacDermott, Rayner (R16) 2021; 397
Hickie, Davenport, Wakefield (R27) 2006; 333
Lee, Shin, Park (R26) 2019; 16
Shea, Reeves, Wells (R44) 2017; 358
Sudre, Murray, Varsavsky (R6) 2020
Huang, Huang, Wang (R12) 2021; 397
Proal, Marshall (R32) 2018; 6
Bansal, Bradley, Bishop (R31) 2012; 26
Islam, Cotler, Jason (R34) 2020; 8
Haas, Angulo, McLaughlin (R2) 2021; 397
Aiyegbusi, Hughes, Turner (R29) 2021; 114
Staniszewska, Brett, Simera (R50) 2017; 358
Page, McKenzie, Bossuyt (R39) 2021; 372
Norton, Olliaro, Sigfrid (R17) 2021; 21
White (R28) 2007; 196
Crook, Raza, Nowell (R37) 2021; 374
Augustin, Schommers, Stecher (R9) 2021; 6
Blomberg, Mohn, Brokstad (R11) 2021
Holgate, Komaroff, Mangan (R36) 2011; 12
Chen, Guo, Zhang (R22) 2019; 2019
Aucott, Rebman (R15) 2021; 397
Ayoubkhani, Khunti, Nafilyan (R10) 2021; 372
Yamato, Kataoka (R33) 2015; 10
Salamanna (2022051704393713000_12.4.e057885.13) 2021; 8
Aucott (2022051704393713000_12.4.e057885.15) 2021; 397
Gorna (2022051704393713000_12.4.e057885.16) 2021; 397
2022051704393713000_12.4.e057885.21
Proal (2022051704393713000_12.4.e057885.32) 2018; 6
2022051704393713000_12.4.e057885.24
2022051704393713000_12.4.e057885.23
2022051704393713000_12.4.e057885.20
Augustin (2022051704393713000_12.4.e057885.9) 2021; 6
2022051704393713000_12.4.e057885.28
2022051704393713000_12.4.e057885.27
Lee (2022051704393713000_12.4.e057885.26) 2019; 16
Rogers (2022051704393713000_12.4.e057885.25) 2020; 7
Norton (2022051704393713000_12.4.e057885.17) 2021; 21
2022051704393713000_12.4.e057885.5
Malik (2022051704393713000_12.4.e057885.30) 2020; 4
2022051704393713000_12.4.e057885.6
2022051704393713000_12.4.e057885.7
2022051704393713000_12.4.e057885.8
2022051704393713000_12.4.e057885.1
2022051704393713000_12.4.e057885.2
2022051704393713000_12.4.e057885.3
2022051704393713000_12.4.e057885.35
2022051704393713000_12.4.e057885.31
2022051704393713000_12.4.e057885.37
2022051704393713000_12.4.e057885.36
2022051704393713000_12.4.e057885.39
2022051704393713000_12.4.e057885.38
Chen (2022051704393713000_12.4.e057885.22) 2019; 2019
Aiyegbusi (2022051704393713000_12.4.e057885.29) 2021; 114
2022051704393713000_12.4.e057885.44
2022051704393713000_12.4.e057885.43
2022051704393713000_12.4.e057885.46
Gupta (2022051704393713000_12.4.e057885.4) 2021; 40
2022051704393713000_12.4.e057885.45
2022051704393713000_12.4.e057885.40
2022051704393713000_12.4.e057885.42
2022051704393713000_12.4.e057885.41
2022051704393713000_12.4.e057885.48
Yamato (2022051704393713000_12.4.e057885.33) 2015; 10
2022051704393713000_12.4.e057885.47
2022051704393713000_12.4.e057885.49
Islam (2022051704393713000_12.4.e057885.34) 2020; 8
2022051704393713000_12.4.e057885.11
2022051704393713000_12.4.e057885.10
2022051704393713000_12.4.e057885.12
2022051704393713000_12.4.e057885.50
2022051704393713000_12.4.e057885.19
2022051704393713000_12.4.e057885.18
2022051704393713000_12.4.e057885.14
References_xml – volume: 8
  year: 2021
  ident: R13
  article-title: Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data
  publication-title: Front Med
  doi: 10.3389/fmed.2021.653516
  contributor:
    fullname: Martini
– volume: 8 Suppl
  start-page: S36
  year: 2003
  ident: R24
  article-title: Sars: prognosis, outcome and sequelae
  publication-title: Respirology
  doi: 10.1046/j.1440-1843.2003.00522.x
  contributor:
    fullname: Mok
– volume: 349
  start-page: g7647
  year: 2015
  ident: R40
  article-title: Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
  publication-title: BMJ
  doi: 10.1136/bmj.g7647
  contributor:
    fullname: Clarke
– start-page: 1
  year: 2021
  ident: R11
  article-title: Long COVID in a prospective cohort of home-isolated patients
  publication-title: Nat Med
  contributor:
    fullname: Brokstad
– volume: 336
  start-page: 924
  year: 2008
  ident: R49
  article-title: Grade: an emerging consensus on rating quality of evidence and strength of recommendations
  publication-title: BMJ
  doi: 10.1136/bmj.39489.470347.AD
  contributor:
    fullname: Vist
– volume: 358
  year: 2017
  ident: R50
  article-title: GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research
  publication-title: BMJ
  contributor:
    fullname: Simera
– volume: 397
  start-page: 1819
  year: 2021
  ident: R2
  article-title: Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)00947-8
  contributor:
    fullname: McLaughlin
– volume: 26
  start-page: 24
  year: 2012
  ident: R31
  article-title: Chronic fatigue syndrome, the immune system and viral infection
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2011.06.016
  contributor:
    fullname: Bishop
– volume: 12
  start-page: 539
  year: 2011
  ident: R36
  article-title: Chronic fatigue syndrome: understanding a complex illness
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn3087
  contributor:
    fullname: Mangan
– volume: 6
  year: 2018
  ident: R32
  article-title: Myalgic Encephalomyelitis/Chronic fatigue syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity
  publication-title: Front Pediatr
  doi: 10.3389/fped.2018.00373
  contributor:
    fullname: Marshall
– volume: 40
  start-page: 1465
  year: 2021
  ident: R4
  article-title: Vaccinations against COVID-19 may have averted up to 140,000 deaths in the United States
  publication-title: Health Aff
  doi: 10.1377/hlthaff.2021.00619
  contributor:
    fullname: Simon
– volume: 397
  start-page: 455
  year: 2021
  ident: R16
  article-title: Long COVID guidelines need to reflect lived experience
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)32705-7
  contributor:
    fullname: Rayner
– volume: 174
  year: 2020
  ident: R5
  article-title: Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2020.106197
  contributor:
    fullname: Cornelissen
– volume: 372
  start-page: n693
  year: 2021
  ident: R10
  article-title: Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study
  publication-title: BMJ
  doi: 10.1136/bmj.n693
  contributor:
    fullname: Nafilyan
– volume: 7
  start-page: 611
  year: 2020
  ident: R25
  article-title: Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(20)30203-0
  contributor:
    fullname: Oliver
– start-page: 2
  year: 2015
  ident: R45
  article-title: The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. secondary the Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses
  publication-title: Ottawa Hosp Res Inst
  contributor:
    fullname: O’Connell
– volume: 12
  start-page: 643
  year: 2018
  ident: R21
  article-title: Recovery of pulmonary functions, exercise capacity, and quality of life after pulmonary rehabilitation in survivors of ARDS due to severe influenza A (H1N1) pneumonitis
  publication-title: Influenza Other Respir Viruses
  doi: 10.1111/irv.12566
  contributor:
    fullname: Cho
– volume: 128
  start-page: 2247
  year: 2005
  ident: R19
  article-title: The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors
  publication-title: Chest
  doi: 10.1378/chest.128.4.2247
  contributor:
    fullname: Ko
– volume: 21
  start-page: 601
  year: 2021
  ident: R17
  article-title: Long COVID: tackling a multifaceted condition requires a multidisciplinary approach
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(21)00043-8
  contributor:
    fullname: Sigfrid
– volume: 6
  year: 2021
  ident: R9
  article-title: Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study
  publication-title: Lancet Reg Health Eur
  doi: 10.1016/j.lanepe.2021.100122
  contributor:
    fullname: Stecher
– volume: 372
  year: 2021
  ident: R39
  article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
  publication-title: BMJ
  contributor:
    fullname: Bossuyt
– volume: 114
  start-page: 428
  year: 2021
  ident: R29
  article-title: Symptoms, complications and management of long COVID: a review
  publication-title: J R Soc Med
  doi: 10.1177/01410768211032850
  contributor:
    fullname: Turner
– volume: 355
  start-page: i4919
  year: 2016
  ident: R47
  article-title: ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
  publication-title: BMJ
  doi: 10.1136/bmj.i4919
  contributor:
    fullname: Reeves
– volume: 366
  year: 2019
  ident: R46
  article-title: Rob 2: a revised tool for assessing risk of bias in randomised trials
  publication-title: BMJ
  doi: 10.1136/bmj.l4898
  contributor:
    fullname: Page
– volume: 397
  start-page: 220
  year: 2021
  ident: R12
  article-title: 6-month consequences of COVID-19 in patients discharged from Hospital: a cohort study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)32656-8
  contributor:
    fullname: Wang
– volume: 16
  start-page: 59
  year: 2019
  ident: R26
  article-title: Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in middle East respiratory syndrome survivors
  publication-title: Psychiatry Investig
  doi: 10.30773/pi.2018.10.22.3
  contributor:
    fullname: Park
– year: 2020
  ident: R6
  article-title: Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms 1 collected by the Covid symptoms study APP 2 3 medRxiv preprint
  publication-title: medRxiv
  contributor:
    fullname: Varsavsky
– volume: 10
  start-page: 203
  year: 2015
  ident: R33
  article-title: Fatigue sensation following peripheral viral infection is triggered by neuroinflammation: who will answer these questions?
  publication-title: Neural Regen Res
  doi: 10.4103/1673-5374.152369
  contributor:
    fullname: Kataoka
– volume: 4
  year: 2020
  ident: R30
  article-title: Cognitive–behavioural therapy combined with music therapy for chronic fatigue following Epstein-Barr virus infection in adolescents: a randomised controlled trial
  publication-title: BMJ Paediatr Open
  doi: 10.1136/bmjpo-2020-000797
  contributor:
    fullname: Pedersen
– volume: 128
  start-page: 1393
  year: 2005
  ident: R20
  article-title: 1-Year pulmonary function and health status in survivors of severe acute respiratory syndrome
  publication-title: Chest
  doi: 10.1378/chest.128.3.1393
  contributor:
    fullname: Lee
– volume: 397
  start-page: 967
  year: 2021
  ident: R15
  article-title: Long-haul COVID: heed the lessons from other infection-triggered illnesses
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)00446-3
  contributor:
    fullname: Rebman
– volume: 333
  start-page: 575
  year: 2006
  ident: R27
  article-title: Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study
  publication-title: BMJ
  doi: 10.1136/bmj.38933.585764.AE
  contributor:
    fullname: Wakefield
– volume: 374
  year: 2021
  ident: R37
  article-title: Long covid-mechanisms, risk factors, and management
  publication-title: BMJ
  doi: 10.1136/bmj.n1648
  contributor:
    fullname: Nowell
– volume: 2019
  start-page: 1
  year: 2019
  ident: R22
  article-title: Long-Term prognosis of suspected myocarditis and cardiomyopathy associated with viral infection of the myocardial tissue: a meta-analysis of cohort studies
  publication-title: Cardiovasc Ther
  doi: 10.1155/2019/9342792
  contributor:
    fullname: Zhang
– volume: 8
  start-page: 61
  year: 2020
  ident: R34
  article-title: Post-Viral fatigue and COVID-19: lessons from past epidemics
  publication-title: Fatigue: Biomedicine, Health Behav
  doi: 10.1080/21641846.2020.1778227
  contributor:
    fullname: Jason
– volume: 196
  start-page: 4
  year: 2007
  ident: R28
  article-title: What causes prolonged fatigue after infectious mononucleosis: and does it tell us anything about chronic fatigue syndrome?
  publication-title: J Infect Dis
  doi: 10.1086/518615
  contributor:
    fullname: White
– volume: 358
  year: 2017
  ident: R44
  article-title: AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
  publication-title: BMJ
  doi: 10.1136/bmj.j4008
  contributor:
    fullname: Wells
– volume: 6
  year: 2006
  ident: R35
  article-title: Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus
  publication-title: BMC Infect Dis
  doi: 10.1186/1471-2334-6-15
  contributor:
    fullname: Cameron
– volume: 84
  start-page: 1001
  year: 2009
  ident: R23
  article-title: Diagnosis and treatment of viral myocarditis
  publication-title: Mayo Clin Proc
  doi: 10.1016/S0025-6196(11)60670-8
  contributor:
    fullname: Cooper
– ident: 2022051704393713000_12.4.e057885.6
  doi: 10.1101/2020.10.19.20214494
– ident: 2022051704393713000_12.4.e057885.5
  doi: 10.1016/j.rmed.2020.106197
– ident: 2022051704393713000_12.4.e057885.41
– volume: 2019
  start-page: 1
  year: 2019
  ident: 2022051704393713000_12.4.e057885.22
  article-title: Long-Term prognosis of suspected myocarditis and cardiomyopathy associated with viral infection of the myocardial tissue: a meta-analysis of cohort studies
  publication-title: Cardiovasc Ther
  contributor:
    fullname: Chen
– ident: 2022051704393713000_12.4.e057885.3
– ident: 2022051704393713000_12.4.e057885.10
  doi: 10.1136/bmj.n693
– ident: 2022051704393713000_12.4.e057885.45
– ident: 2022051704393713000_12.4.e057885.12
  doi: 10.1016/S0140-6736(20)32656-8
– ident: 2022051704393713000_12.4.e057885.50
  doi: 10.1136/bmj.j3453
– volume: 8
  year: 2021
  ident: 2022051704393713000_12.4.e057885.13
  article-title: Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data
  publication-title: Front Med
  doi: 10.3389/fmed.2021.653516
  contributor:
    fullname: Salamanna
– ident: 2022051704393713000_12.4.e057885.19
  doi: 10.1378/chest.128.4.2247
– ident: 2022051704393713000_12.4.e057885.47
  doi: 10.1136/bmj.i4919
– ident: 2022051704393713000_12.4.e057885.11
– ident: 2022051704393713000_12.4.e057885.35
  doi: 10.1186/1471-2334-6-15
– volume: 21
  start-page: 601
  year: 2021
  ident: 2022051704393713000_12.4.e057885.17
  article-title: Long COVID: tackling a multifaceted condition requires a multidisciplinary approach
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(21)00043-8
  contributor:
    fullname: Norton
– ident: 2022051704393713000_12.4.e057885.28
  doi: 10.1086/518615
– ident: 2022051704393713000_12.4.e057885.42
– volume: 397
  start-page: 967
  year: 2021
  ident: 2022051704393713000_12.4.e057885.15
  article-title: Long-haul COVID: heed the lessons from other infection-triggered illnesses
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)00446-3
  contributor:
    fullname: Aucott
– ident: 2022051704393713000_12.4.e057885.40
  doi: 10.1136/bmj.g7647
– ident: 2022051704393713000_12.4.e057885.2
  doi: 10.1016/s0140-6736(21)00947-8
– ident: 2022051704393713000_12.4.e057885.36
  doi: 10.1038/nrn3087
– volume: 6
  year: 2018
  ident: 2022051704393713000_12.4.e057885.32
  article-title: Myalgic Encephalomyelitis/Chronic fatigue syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity
  publication-title: Front Pediatr
  doi: 10.3389/fped.2018.00373
  contributor:
    fullname: Proal
– volume: 10
  start-page: 203
  year: 2015
  ident: 2022051704393713000_12.4.e057885.33
  article-title: Fatigue sensation following peripheral viral infection is triggered by neuroinflammation: who will answer these questions?
  publication-title: Neural Regen Res
  doi: 10.4103/1673-5374.152369
  contributor:
    fullname: Yamato
– volume: 16
  start-page: 59
  year: 2019
  ident: 2022051704393713000_12.4.e057885.26
  article-title: Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in middle East respiratory syndrome survivors
  publication-title: Psychiatry Investig
  doi: 10.30773/pi.2018.10.22.3
  contributor:
    fullname: Lee
– volume: 6
  year: 2021
  ident: 2022051704393713000_12.4.e057885.9
  article-title: Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study
  publication-title: Lancet Reg Health Eur
  contributor:
    fullname: Augustin
– ident: 2022051704393713000_12.4.e057885.23
  doi: 10.4065/84.11.1001
– volume: 114
  start-page: 428
  year: 2021
  ident: 2022051704393713000_12.4.e057885.29
  article-title: Symptoms, complications and management of long COVID: a review
  publication-title: J R Soc Med
  doi: 10.1177/01410768211032850
  contributor:
    fullname: Aiyegbusi
– ident: 2022051704393713000_12.4.e057885.24
  doi: 10.1046/j.1440-1843.2003.00522.x
– ident: 2022051704393713000_12.4.e057885.27
  doi: 10.1136/bmj.38933.585764.AE
– volume: 8
  start-page: 61
  year: 2020
  ident: 2022051704393713000_12.4.e057885.34
  article-title: Post-Viral fatigue and COVID-19: lessons from past epidemics
  publication-title: Fatigue: Biomedicine, Health Behav
  contributor:
    fullname: Islam
– volume: 40
  start-page: 1465
  year: 2021
  ident: 2022051704393713000_12.4.e057885.4
  article-title: Vaccinations against COVID-19 may have averted up to 140,000 deaths in the United States
  publication-title: Health Aff
  doi: 10.1377/hlthaff.2021.00619
  contributor:
    fullname: Gupta
– ident: 2022051704393713000_12.4.e057885.43
– volume: 7
  start-page: 611
  year: 2020
  ident: 2022051704393713000_12.4.e057885.25
  article-title: Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(20)30203-0
  contributor:
    fullname: Rogers
– ident: 2022051704393713000_12.4.e057885.18
– ident: 2022051704393713000_12.4.e057885.21
  doi: 10.1111/irv.12566
– ident: 2022051704393713000_12.4.e057885.49
  doi: 10.1136/bmj.39489.470347.AD
– ident: 2022051704393713000_12.4.e057885.14
– ident: 2022051704393713000_12.4.e057885.39
  doi: 10.1136/bmj.n71
– ident: 2022051704393713000_12.4.e057885.46
  doi: 10.1136/bmj.l4898
– ident: 2022051704393713000_12.4.e057885.20
  doi: 10.1378/chest.128.3.1393
– ident: 2022051704393713000_12.4.e057885.8
– volume: 4
  year: 2020
  ident: 2022051704393713000_12.4.e057885.30
  article-title: Cognitive–behavioural therapy combined with music therapy for chronic fatigue following Epstein-Barr virus infection in adolescents: a randomised controlled trial
  publication-title: BMJ Paediatr Open
  contributor:
    fullname: Malik
– ident: 2022051704393713000_12.4.e057885.37
  doi: 10.1136/bmj.n1648
– ident: 2022051704393713000_12.4.e057885.48
– ident: 2022051704393713000_12.4.e057885.1
– volume: 397
  start-page: 455
  year: 2021
  ident: 2022051704393713000_12.4.e057885.16
  article-title: Long COVID guidelines need to reflect lived experience
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)32705-7
  contributor:
    fullname: Gorna
– ident: 2022051704393713000_12.4.e057885.38
– ident: 2022051704393713000_12.4.e057885.31
  doi: 10.1016/j.bbi.2011.06.016
– ident: 2022051704393713000_12.4.e057885.7
  doi: 10.1101/2021.06.28.21259452
– ident: 2022051704393713000_12.4.e057885.44
  doi: 10.1136/bmj.j4008
SSID ssj0000459552
Score 2.3951402
Snippet IntroductionPostviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the...
Postviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the SARS-CoV-2...
INTRODUCTIONPostviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to the...
Introduction Postviral syndromes (PVS) describe the sustained presence of symptoms following an acute viral infection, for months or even years. Exposure to...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
bmj
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e057885
SubjectTerms Bias
Chronic fatigue syndrome
Coronaviruses
COVID-19
COVID-19 - complications
COVID-19 - therapy
Epstein-Barr virus
Humans
INFECTIOUS DISEASES
Long COVID
Meta-analysis
Meta-Analysis as Topic
Post-Acute COVID-19 Syndrome
Public Health
REHABILITATION MEDICINE
Research Design
SARS-CoV-2
Syndrome
Systematic review
Systematic Reviews as Topic
Viral infections
SummonAdditionalLinks – databaseName: BMJ Open Access Journals
  dbid: 9YT
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3faxQxEA61QimIaNV6WiWCDz50e7dJJpv4ptVSxdaXVurTkuQSrbS7R2_vyX_emf1x54mIL7uwGbIhM5N8k2S-MPbSKxNMApXFqU2ZKiY2c3oaMwfJgpiCmEwpUfjkVB-fq48XcLHB8iEXxl__oGujDvDdZTQQR1PVjHMxVuOI4MIYOKCV6VvsNoAEuq3Bfj1bLqsgQrHQ3rMjJkplCNah5xrKpR5qR9MQGES3lW2zLQmKSJWIOBAF1iaolsf_b-DzzzOUv01KR_fY3R5N8jed-u-zjVjtsK2Tfr98h93pVuV4l2z0gP08ratstmKrJg3xLgULI2aOAJbP6nlDB3-v-EBmMN_nl1W4WtAsxz_V-Dj8_OXDu9fc8RUPNO9yYLirpvw6Ni5zPdsJJyaIGv_2kJ0fvT87PM766xcyD9I2WRQpof8XIjmdksudpIQFDejBxHiDI5NxwudeKGlg4k0RXZJ57mwuUhTWyEdss6qr-Jhx9HSnpACvUlA6BJ98IUEnBckkxKAj9gp7vuzdZ162kYnUZa-vkvRVdvoasf1BPeWsI-T4t_hbUuFSlNi02w_1zbeyd87Sh8ImE2PwgNGqK7zOQxEMuCCDdlqM2N5gAKs2IpK0FK2qYsReLIvROWnHxVWxXnQygCPiBGV2O3tZtmSwuhEr1ixpranrJdXl95YA3BLyAvPk_3vtKdsWlLdBJJX5HttsbhbxGaKpxj9v_ecX550aYA
  priority: 102
  providerName: BMJ Publishing Group Ltd
– databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV29b9UwELegA2JBfBNakJEYGBo1sX2OzQaFqiBaFoq6RbZjq0Vt8sTLm_rPc5fkfSEEC0sG-yRffB--k32_Y-y1VyaYBCqPjU25qgqbO93E3EGyIBoQRUOFwien-vhMfT6H841WX_QmbIQHHjfuwIfKJhNj8ICZhKu8LkMVDLggg3aT9y3ERjI1-GAFFkBMMEOl1Af--gf1o0KtEJg_o55S9-TbOLp1IA24_X8KNn9_M7lxCB3dZ_em6JG_G7l-wG7F9iG7czLdjz9iN6ddm8_WaNQkAT6WWGFGzDFA5bNu3tPD3iu-BCuY7_PLNlwt6BTjXzr8HH79_unDW-74GueZjzUu3LUNv469y92EZsIJ6aHD1R6zs6OP3w6P86m9Qu5B2j6PIiW070okp1NypZNUkKABLZQQbdDzGCd86YWSBgpvquiSLEtnS5GisEY-YTtt18ZnjKMlOyUFeJWC0iH45CsJOilIJmGMmbE3uNP1ZB7zesg8pK4nodQklHoUSsb2l-KoZyPgxt_J35PIVqSElj0MoA7Vkw7V_9KhjO0tBb7mESNFS9moqjL2ajWNxkc3Kq6N3WKkAfR4BdI8HfVjxYkERVBdMmPVluZssbo9015eDADfliIrMM__x7_tsruCKjYInrLcYzv9z0V8gXFU718OJvMLzFIeAA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Coronavirus Research Database
  dbid: COVID
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZoKyEuvCmBgozEgUPdbvxKzAVBoSqIlgtFvUW2Y0OhTZZu9gJ_npnE2WUr1AOXHJyRYucbj2dszzeEPHey9GVUkoXaRCaLiWFW14FZFY3iteKTGhOFD4_0wbH8cKJO0obbLF2rHG1ib6jr1uMe-S4s3AaDA1m8mv5kWDUKT1dTCY01siHAdQAN39j79OX928UuCzgsRime6IZyoXfd-XesSwXawSGOBn3FKspr0LqyMPX8_f9yOi_fnfxrMdq_RapxGMMdlB87887t-F-XGB7_f5y3yc3kp9LXg2LdIddCc5dcP0wn8ffI76O2YdMl7zViTYdkLoi9KbjCdNrOOrxCfEZHWoTZNj1t_Nkc10v6sYVH_x9fUkuXjNJ0yKahtqnpeegss4k3hSKnRAtfu0-O99993jtgqZADc0qYjgUeI1iSgkerY7S5FZj6oBXYAuTOARtXWu5yxyWgOHFlEWwUeW5NzmPgphQPyHrTNuEhoWAzrBRcORm91N676AqhdJQqlhG82Yy8ACyrNBFnVR_jCF0l2CuEvRpgz8j2CHg1Hag9rhZ_g0qxEEVe7r6hvfhapWleOV-YWIbgnYK41xZO577wpbJeeG01z8jWiPqyj0vIM_Js8RqmOZ7d2Ca080FGgW2dgMzmoIGLngglkRRMZKRY0c2Vrq6-aU6_9VTiBn04VT66uluPyQ2OWR9IcZlvkfXuYh6egC_Wuadpwv0Bn2U4vQ
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Ni9QwFA_rCuJF_La6SgQPHjba5quJIKKryyrOenFkbyVJE12ZbceZDij-87606Ywjq-Clhya04X3k_R7J-z2EHlmunAqCE1_rQHiZa2Jk7YkRQQtaC5rXsVB4ciyPpvzdiTjZQWNX1CTA5bmpXewnNV3Mnnz_9uMFOPzz1JHkqT37GodA4RRSYzBBJS6gixRCY7zjNUl4v9-audCi78JDc84JQHmRmIj-8h2IOPB2K2b11P7n4dE_r1X-FqcOr6IrCWDil4NFXEM7vrmOLk3SEfoN9PO4bch8Q1gdlYSHKixImjFgWDxvl128-zvDI5_Bch-fNm62ioEOv2_hcfDh09vXz7DBGypoPJTBYNPU-Mx3hphEeIIjGUQLf7uJpodvPh4ckdSBgVjBdEc8DQG2gJIGI0MwhWGxZkEKcOJIegObkzLUFhZkrURuVelNYEVhdEGDp1qxW2i3aRt_B2FwdsMZFZYHx6VzNtiSCRm4CCoADM3QY5B0NRpA1ScnTFZJKVVUSjUoJUP7ozqq-cDJ8e_pr6LK1lMjoXb_ol18rpJ_VtaVOijvnRWQsJrSysKVTgnjmJNG0gztjQrfrBHApI4JKy8z9HA9DP4ZD11M49vVMEfAppjDnNuDfaxXwgSPbF4sQ-WW5WwtdXukOf3Sc4DrCL6Euvt_oriHLtNYvhG5Kos9tNstVv4-gKrOPugd5Reu-x_Z
  priority: 102
  providerName: Scholars Portal
Title Non-pharmacological therapies for postviral syndromes, including Long COVID: a systematic review and meta-analysis protocol
URI https://bmjopen.bmj.com/content/12/4/e057885.full
https://www.ncbi.nlm.nih.gov/pubmed/35410933
https://www.proquest.com/docview/2649289947
https://search.proquest.com/docview/2649587007
https://pubmed.ncbi.nlm.nih.gov/PMC9002258
https://doaj.org/article/bc79f8eecb5448a7b61c7c85ac3c6a62
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe2ISEkhGB8BUZlJB54WNbGX7F528rGQKRMaJvKU2Q7NhS1SbW2T_zznPPRrgjxwIsjJRfFyv3Od5fc_YzQG8OklZ6z2BXKxywdqFiLwsWae8VJwcmgCI3C2UicX7FPYz7eQbzrhamL9q2ZHJXT2VE5-VHXVs5ntt_VifUvsqEKnofL_i7aBfd7K0Wvl1_GFeekZRhKqOib2c-wFRUAgkDqDBCVYb8aylmgUgp0gSCw5ZZq9v6_hZx_Vk7eckVnD9GDNobEx81cH6EdV-6ju1n7l3wf3W--xeGmxegx-jWqyni-4agOesFN4xXkyRjCVjyvFstQ7jvFHYXB4hBPSjtdBd-GP1cwDL9cf3z_Dmu8YX_GTecL1mWBZ26pY91ynODA_1DB056gq7PTy-F53G66EBtO1TJ2xHuw-pR4LbzXiaahTUFwsNvAcwPrkdTEJIYwKvnAyNRpT5NEq4R4R5SkT9FeWZXuOcJg35pRwg3zlglrjTcp5cIz7qWHyDNCb-HN563RLPI6H6Eib_WVB33ljb4idNipJ583NBz_Fj8JKlyLBg7t-kR18z1vkZQbmyovnbOGQ46qUyMSm1rJtaVWaEEidNABYDNHiB9VyFFZGqHX68tgkuE_iy5dtWpkOKyDA5B51uBlPZMOdRFKt5C0NdXtK2AFNe13i_oX_33nS3SPhOaNwFSZHKC95c3KvYKQaml6YEjjFEb17bKH7hwPs-wajieno4uvcKzx1as_V8D4YZzAmDHZqw3vN77MK5A
link.rule.ids 230,314,727,780,784,864,885,2102,2221,12056,21388,24318,27924,27925,31719,31720,33744,33745,38516,43310,43805,43895,53791,53793,55349,55350,73745,74302,74412,77660,77686,77707
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELXoVgIufBcCBYzEgUPTbuzYSbggKFRb2F0uLerNsh0bCm2ydLMX-PPMJM4uW6EeuOTgjBQ7bzyesT1vCHlp0tzmXqSxKwsfp9mwiLUsXayFLwQrBRuWmCg8mcrRcfrxRJyEDbd5uFbZ28TWUJe1xT3yPVi4CwwO0uzN7GeMVaPwdDWU0Nggm1jFWwzI5v7nL4fvl7ss4LAUQrBAN5RwuWfOv2NdKtAOBnE06CtWUd6A1rWFqeXv_5fTefnu5F-L0cFtovphdHdQfuwuGrNrf11iePz_cd4ht4KfSt92inWXXHPVPXJ9Ek7i75Pf07qKZyvea8SadslcEHtTcIXprJ43eIX4jPa0CPMdelrZswWul3Rcw6P9j6-ppitGadpl01BdlfTcNTrWgTeFIqdEDV97QI4PPhztj-JQyCE2ghdN7Jj3YEky5rX0XieaY-qDFGALkDsHbFyumUkMAxDF0OSZ054niS4S5h0rcr5FBlVduUeEgs3QKWfCpN6m0lrjTcaF9KnwuQdvNiKvAEsVJuJctTEOlyrArhB21cEekZ0ecDXrqD2uFn-HSrEURV7utqG--KrCNFfGZoXPnbNGQNyrMyMTm9lcaMut1JJFZLtHfdXHFeQRebF8DdMcz2505epFJyPAtg5B5mGngcuecJEiKRiPSLamm2tdXX9TnX5rqcQL9OFE_vjqbj0nN0ZHk7EaH04_PSE3GWaAIN1lsk0GzcXCPQW_rDHPwuT7A30nO60
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELboVqq4IN4NFDASBw6NduNXYi6IPlYttEuFKOotsh0bitpk6WZP_HlmEu8ui1AvOTgjxcq87ZlvCHljReGKIEXqKx1SkY90alTlUyODlqySbFRho_DpRB2di48X8iLWP81iWeXCJnaGumocnpEPwXFrTA5EPgyxLOLsYPx--ivFCVJ40xrHaWyQTfCKIzYgm3uHk7MvyxMXCF60lCxCD2VcDe31T5xRBZLCIKcG2cWJyhuwuuakOiz__wWg_9ZR_uWYxvfJvRhR0g-9CDwgd3z9kGydxjvzR-T3pKnT6QqhGrlC-7YryJIpBK102sxaLPa9ogsAg9kuvazd1Rw9Gz1p4LH_-dvxwTtq6Ar7mfZ9L9TUFb32rUlNRDihiP7QwNcek_Px4df9ozSOXEit5LpNPQsBdD5nwagQTGY4NikoCVqLKDdgjQrDbGaZ4IUc2SL3JvAsMzpjwTNd8CdkUDe13yYUtNsIzqQVwQnlnA0251IFIUMRIO5MyFv402VUmVnZZSNclZEpJTKl7JmSkN0FO8ppD8JxO_kesmxJigja3UJz872MCllal-tQeO-shAzV5FZlLneFNI47ZRRLyM6C4as9roQwIa-Xr0Eh8ZbF1L6Z9zQSrOAIaJ728rHcCZcC4bt4QvI1yVnb6vqb-vJHB_qtMdqSxbPbt_WKbIFWlCfHk0_PyV2GrRqIS5ntkEF7M_cvIIBq7cuoGX8AdTkc3Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Non-pharmacological+therapies+for+postviral+syndromes%2C+including+Long+COVID%3A+a+systematic+review+and+meta-analysis+protocol&rft.jtitle=BMJ+open&rft.au=Chandan%2C+Joht+Singh&rft.au=Brown%2C+Kirsty&rft.au=Simms-Williams%2C+Nikita&rft.au=Camaradou%2C+Jenny&rft.date=2022-04-11&rft.issn=2044-6055&rft.eissn=2044-6055&rft.volume=12&rft.issue=4&rft.spage=e057885&rft_id=info:doi/10.1136%2Fbmjopen-2021-057885&rft.externalDBID=n%2Fa&rft.externalDocID=10_1136_bmjopen_2021_057885
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2044-6055&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2044-6055&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2044-6055&client=summon